Journal of studies on alcohol and drugs

Negative Effects Described in Reports of Recreational Psychedelic and Non-Psychedelic Drug Use

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

A psycholinguistic assessment identified adverse effects of popular psychedelic substances based on online experience reports.

  • Psychedelic substances, including LSD and psilocybin, have been the subject of increased research, yet their adverse effects in recreational use remain underexplored.
  • Online experience reports provide a valuable source of information regarding the negative effects associated with these substances.
  • The analysis aimed to infer psychologically relevant outcomes from natural language descriptions of experiences.
  • Findings suggest that adverse effects may vary among different psychedelic substances.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Jan '22
Experiences of Recreational Psychedelic Use Grouped by Substance
top 20% journal
cited by 26 papers
journal article
Sep '24
Psychedelic-assisted therapy for anxiety, depression, and distress in people with serious illnesses
cited by 25 papers
systematic review
Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 30 papers
systematic review
Apr '26
Psychedelic Use During Pregnancy: An Overview to Guide Drug Safety and Medical Advice Around Birth
top 20% journal
journal article
Jan '26
Reported side effects of classic psychedelics and MDMA in the general population using WHO safety data
top 10% journal
cited by 2 papers
journal article
Apr '22
Psychedelics as Possible New Treatments for Mood and Anxiety Disorders
top 20% journal
cited by 49 papers
journal article
Oct '24
How Study Design Relates to Antidepressant Effects in Psychedelic Therapy: A Meta-Analysis
top 5% journal
cited by 1 paper
meta-analysis

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the psychedelic science brief

issue #53
One psilocybin session held antidepressant effects for 52 weeks in a new follow-up study
2 weeks ago7 studies
issue #52
Psilocybin didn't create disorder in the brain — it created a different kind of order
3 weeks ago7 studies
issue #51
Psilocybin worked for treatment-resistant depression in real Swiss clinics — not just controlled trials
4 weeks ago7 studies
issue #50
Psilocybin beat placebo on depression scores in an NHS trial — by a lot
5 weeks ago7 studies
issue #49
Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means
6 weeks ago7 studies
issue #48
Psychedelics during adolescence reshaped adult social behavior in rats — here's the circuit
7 weeks ago7 studies
issue #47
Psilocybin rewired prefrontal circuits in mice — but only for one specific type of cognitive failure
8 weeks ago7 studies
issue #46
Psilocybin cut two specific brain chemicals in depressed patients — here's what that means
9 weeks ago7 studies
issue #44
Psilocybin rewires brain feedback circuits for weeks after a single dose, new evidence shows
10 weeks ago7 studies
issue #43
A pill form of ketamine cut dissociation to near-zero vs. nasal spray's 29.6-point spike — but missed its main antidepressant target
11 weeks ago7 studies
explore the archive
See more issues from the psychedelic science brief